Physician profile
Marcus J Malone
NPI 1437374683
$1,657.78
in general payments reported to CMS, 2019-2025
24 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $580 · 2020: $483 · 2021: $343 · 2022: $115 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $137.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $201.59 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $178.89 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $171.94 | 2019-2022 | |
| Medtronic USA, INC. | $155.73 | 2020 | |
| Biodelivery Sciences International, INC. | $140.98 | 2019-2021 | |
| Saluda Medical Americas, INC. | $122.63 | 2025 | Evoke |
| Vertiflex, INC. | $110.88 | 2019 | |
| Arbor Pharmaceuticals, INC. | $106.24 | 2019-2021 | |
| Medtronic, INC. | $76.72 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.64 | 2019-2021 | |
| Boston Scientific Corporation | $53.11 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $42.85 | 2019-2025 | Exparel |
| Radius Health, INC. | $40.89 | 2020-2022 | |
| Redhill Biopharma INC. | $38.29 | 2021 | |
| Scilex Pharmaceuticals INC. | $29.59 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $19.49 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $17.91 | 2022 | |
| Bioventus LLC | $17.38 | 2021 | |
| Orthofix Medical, INC. | $16.73 | 2022 | |
| Eagle Pharmaceuticals, INC. | $14.55 | 2019 | |
| Horizon Therapeutics Plc | $13.08 | 2019 | |
| Nevro Corp. | $12.68 | 2019 | |
| Daiichi Sankyo INC. | $11.59 | 2019 | |
| Forte Bio-Pharma LLC | $9.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Malone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.